| Literature DB >> 25288282 |
Alice Stoneman1, David Atkinson, Maureen Davey, Julia V Marley.
Abstract
BACKGROUND: Management of chronic disease, including diabetes, is a central focus of most Aboriginal Community Controlled Health Services (ACCHSs) in Australia. We have previously demonstrated that diabetes monitoring and outcomes can be improved and maintained over a 10-year period at Derby Aboriginal Health Service (DAHS). While continuous quality improvement (CQI) has been shown to improve service delivery rates and clinical outcome measures, the process of interpreting audit results and developing strategies for improvement is less well described. This paper describes the evaluation of care of patients with type 2 diabetes mellitus (T2DM) and features of effective CQI in ACCHSs in the remote Kimberley region of north Western Australia.Entities:
Mesh:
Year: 2014 PMID: 25288282 PMCID: PMC4282197 DOI: 10.1186/1472-6963-14-481
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Proportion of patients for whom diabetes management activities were recorded in the electronic patient and information recall system during the audit period, and corresponding values from the final years of other studies
| Study sites | National indigenous PHC § | DAHS 2008-09 ¶ | |||||
|---|---|---|---|---|---|---|---|
| DAHS | ACCHS-2 | ACCHS-3 | ACCHS-4 | All ACCHS | |||
| No. of patients included in the study | 156 | 76 | 87 | 29 | 348 | ||
| Proportion female | 66% | 79% | 57% | 55% | 66% | ||
| Median age | 55 | 52 | 46 | 55 | 52 | ||
| Age range | 22 - 88 | 25 - 88 | 19 - 82 | 30 - 87 | 19 - 88 | ||
| Blood pressure† | 80% | 80% | 84% | 55%* | 79% | 70-88 | 80% |
| HbA1c † | 71% | 82% | 59% | 28% | 66% | 56-74 | 74% |
| Weight† | 72% | 70% | 56%* | 48%* | 66% | 51-77 | 74% |
| Urine protein‡ | 53% | 49% | 52% | 28%* | 50% | 42-63 | |
| ACR‡ | 67% | 72% | 71% | 31%* | 66% | 46-65 | 81% |
| eGFR‡ | 94% | 89% | 87% | 48%* | 88% | 94% | |
| Cholesterol‡ | 79% | 76% | 71% | 38%* | 73% | 91% | |
| Liver function tests‡ | 92% | 87% | 83%* | 48%* | 85% | ||
| Full foot check‡ | 14% | 5%* | 5%* | 3% | 9% | 4-40 | |
| Retinal screen‡ | 35% | 26% | 24% | 0%* | 28% | 29-56 | |
| Diet and physical activity† | 33% | 22%* | 1%* | 0% | 20% | 19-56 | |
| Smoking assessment† | 48% | 28%* | 1%* | 7%* | 28% | 24-92 | 85% |
| GPMP‡ | 27% | 11%* | 15%* | 28% | 20% | ||
DAHS = Derby Aboriginal Health Service. PHC = primary health care. HbA1c = glycated haemoglobin. eGFR = estimated glomerular filtration rate. ACR = albumin creatinine ratio. GPMP = general practice management plans.
*Significant difference compared with DAHS p < 0.05.
§Australian Aboriginal and Torres Strait Islander patients treated in PHC settings [30, 34–36].
Final year of the “DAHS diabetes study” [28].
†Recorded from 1 Jan 2012 to 30 June 2012.
‡Recorded from 1July 2011 to 30 June 2012.
Clinical outcome measures and proportion of patients whose outcome values met recommended clinical targets, and corresponding values from the final years of other studies
| Study sites | National indigenous PHC ‡ | DAHS 2008-09 ¶ | |||||
|---|---|---|---|---|---|---|---|
| DAHS | ACCHS-2 | ACCHS-3 | ACCHS-4 | All ACCHSs | |||
| Median annual clinical outcome measures | |||||||
| HbA1c (%) | 8 | 8.5 | 8.7† | 8.1 | 8.2 | 8.8-9.2 | 8.0 |
| BP systolic (mmHg) | 127 | 130 | 125 | 135* | 128 | 126-133 | 120 |
| BP diastolic (mmHg) | 77 | 80 | 80† | 83* | 78 | 77-80 | 75 |
| Total cholesterol (mmol/L) | 4.4 | 4.6 | 4.8* | 4.2 | 4.5 | 4.7-4.8 | 4.5 |
| ACR | 8.7 | 15.6 | 44.1* | 3.6 | 15.6 | 5.9-7.1 | |
| Proportion of study population with median values that met targets | |||||||
| HbA1c ≤7% | 31% | 25% | 16%* | 17% | 26% | 16-32 | 34% |
| BP ≤130/80** | 53% | 47% | 48% | 19%* | 38% | 28-64 | 69% |
| Total cholesterol ≤4 mmol/L | 39% | 42% | 19%* | 27% | 34% | 29 | 25% |
| ACR <3.6 mg/mmol | 38% | 29% | 16%* | 44% | 30% | 38 | |
DAHS = Derby Aboriginal Health Service. PHC = primary health care. HbA1c = glycated haemoglobin. BP = blood pressure. ACR = albumin creatinine ratio.
‡Australian Aboriginal and Torres Strait Islander patients treated in PHC settings [29, 30, 34–37].
Final year of the “DAHS diabetes study” [28].
*Statistically significant difference (P ≤ 0.05) when compared with ACCHS 1.
†Approached statistical significance when compared with DAHS (P = 0.05).
**At least half of each participant’s recorded measurements met the recommended target for both systolic and diastolic BP.
Comparison of quantitative and qualitative results
| DAHS | ACCHS-2 | ACCHS-3 | ACCHS-4 | |
|---|---|---|---|---|
|
| ++ | ++ | ++ | - |
|
| ++ | + | - | N/A |
|
| ++ | + | - | - |
|
| ++ | + | - | - |
|
| ++ | + | + | + |
|
| - | + | - | - |
*++ = High, + = Moderate, − = Low.
†++ = Good, + = Moderate, − = Poor.
‡++ = Done well, + = Done to some extent, − = Not done.
N/A = not applicable as clinical outcome measures at ACCHS-4 unable to be interpreted due to very small patient numbers.